Last reviewed · How we verify
NCT07148973
Outcomes for Patients With Ascending Aortic Dilation Who Underwent TAVR
trial testing Transcatheter Aortic Valve Replacement in Transcatheter Aortic Valve Replacement (TAVR) in 101 participants. Completed in 31 July 2021.
31 July 2021
Quick facts
| Lead sponsor | zjq |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 101 |
| Start date | 1 January 2019 |
| Primary completion | 31 July 2021 |
| Estimated completion | 31 July 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Transcatheter Aortic Valve Replacement
Conditions studied
- Transcatheter Aortic Valve Replacement (TAVR) — all drugs for Transcatheter Aortic Valve Replacement (TAVR) →
- Ascending Aortic Dilation — all drugs for Ascending Aortic Dilation →
Sponsor
zjq
Who can join
Adults 50 to 93, any sex, with Transcatheter Aortic Valve Replacement (TAVR) or Ascending Aortic Dilation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study was designed to evaluate the safety of TAVR with a preoperative ascending aortic (AA) diameter ≥ 40 mm. This study also aimed to explore the procedural outcomes and clinical prognoses of patients with AAD combined compared to those of patients without AAD combined who underwent TAVR. Between January 2019 and July 2021, a total of 186 patients who were diagnosed at a single centre with severe AS underwent the TAVR procedure using a self-expanding valve. The AA diameter was evaluated via 3-dimensional (3D) multidetector computed tomography (MDCT) before TAVR. AAD was defined as a value of AAD ≥ 40 mm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07148973
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcatheter Aortic Valve Replacement
Trials testing the same drug.
- NCT07450196 — A Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Val · not yet recruiting
- NCT07413965 — TAVR vs SAVR in Severe Bicuspid Aortic Stenosis · NA · not yet recruiting
- NCT07145463 — Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aorti · NA · recruiting
- NCT05171712 — Portico and Navitor India Clinical Trial · NA · completed
- NCT05002088 — Portico Valve-in-Valve Retrospective Registry · completed
Other recruiting trials for Transcatheter Aortic Valve Replacement (TAVR)
Currently open trials in the same condition.
- NCT07365345 — Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients · NA · recruiting
- NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
- NCT07107568 — Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter, Non-Infe · NA · recruiting
- NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
- NCT06818084 — TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07148973 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by zjq
- Last refreshed: 8 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07148973.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing